Bowel cancer screening using a home kit called a faecal immunochemical test (FIT) is currently available for those aged 54 to ...

Mainz Biomed has announced a partnership with Quest Diagnostics to support the commercialisation of its NextGen colorectal ...

Quest to Support Mainz Biomed’s ReconAAsense FDA Study and Has Option to Commercialize Test Kit Assuming FDA ApprovalBERKELEY ...

THE FESTIVE season is all about spending time with loved ones, celebrations and, of course, overindulgence. With the average ...

The company’s main revenue source is Cologuard, a non-invasive pre- and colorectal cancer [CRC] screening test that was first ...

In most cases it won’t be cancer, but if it is, spotting it early can make a real difference.” FIT (faecal immunochemical test) that looks for tiny traces of blood in a sample of faeces ...

Pancreatic Cancer UK, who are working on developing the breath test, believe this new research could save thousands of lives each year. Pancreatic cancer is frequently diagnosed at an advanced ...

and subtle changes in bowel habits including blood in her stool. One of the most common cancers that is affecting people worldwide due to their dietary or lifestyle habits is bowel cancer.

A new AI-powered blood test is the first to detect signs of breast cancer in its earliest stages when it is “far more easily treated”, scientists have announced. The new fast and non-invasive ...